AA
MGNX icon

ALPS Advisors’s MacroGenics MGNX Stock Holding History

ALPS Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-48,646
Closed -$61.8K – 1046
2025
Q1 		$61.8K Sell
48,646
-2,104
-4% -$5.5K ﹤0.01% 985
2024
Q4 		$165K Buy
+50,750
New +$183K ﹤0.01% 977
2024
Q2 		– Sell
-43,752
Closed -$644K – 986
2024
Q1 		$644K Buy
43,752
+2,078
+5% +$31.4K ﹤0.01% 562
2023
Q4 		$401K Sell
41,674
-4,020
-9% -$27.8K ﹤0.01% 669
2023
Q3 		$213K Buy
45,694
+241
+0.5% +$1.2K ﹤0.01% 956
2023
Q2 		$243K Buy
+45,453
New +$280K ﹤0.01% 953
2022
Q2 		– Sell
-63,024
Closed -$555K – 1075
2022
Q1 		$555K Sell
63,024
-7,865
-11% -$86.8K 0.01% 417
2021
Q4 		$1.14M Sell
70,889
-4,008
-5% -$75.4K 0.01% 344
2021
Q3 		$1.57M Sell
74,897
-4,180
-5% -$101K 0.02% 345
2021
Q2 		$2.12M Buy
+79,077
New +$2.32M 0.02% 318
2020
Q2 		– Sell
-88,930
Closed -$518K – 813
2020
Q1 		$518K Sell
88,930
-10,372
-10% -$94.2K 0.01% 431
2019
Q4 		$1.08M Buy
99,302
+1,815
+2% +$18K 0.01% 332
2019
Q3 		$1.24M Sell
97,487
-4,656
-5% -$67.1K 0.01% 270
2019
Q2 		$1.73M Sell
102,143
-15,179
-13% -$261K 0.01% 245
2019
Q1 		$2.11M Buy
117,322
+19,659
+20% +$340K 0.01% 221
2018
Q4 		$1.24M Buy
97,663
+22,921
+31% +$384K 0.01% 260
2018
Q3 		$1.6M Buy
74,742
+13,500
+22% +$288K 0.01% 280
2018
Q2 		$1.26M Buy
+61,242
New +$1.38M 0.01% 292
2017
Q4 		– Sell
-36,239
Closed -$670K – 865
2017
Q3 		$670K Buy
36,239
+4,635
+15% +$80.3K ﹤0.01% 317
2017
Q2 		$553K Buy
31,604
+1,635
+5% +$31.2K ﹤0.01% 409
2017
Q1 		$557K Sell
29,969
-3,508
-10% -$67.7K ﹤0.01% 317
2016
Q4 		$684K Sell
33,477
-10,802
-24% -$272K 0.01% 246
2016
Q3 		$1.32M Sell
44,279
-4,251
-9% -$126K 0.01% 208
2016
Q2 		$1.31M Buy
48,530
+9,942
+26% +$224K 0.01% 199
2016
Q1 		$724K Sell
38,588
-6,613
-15% -$126K 0.01% 198
2015
Q4 		$1.4M Sell
45,201
-8,325
-16% -$253K 0.01% 197
2015
Q3 		$11.5K Buy
53,526
+23,721
+80% +$744K 0.01% 207
2015
Q2 		$1.13M Buy
29,805
+15,084
+102% +$496K 0.01% 206
2015
Q1 		$462K Buy
+14,721
New +$499K ﹤0.01% 609

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ALPS Advisors's MGNX Position: Q2 2025 in Review

ALPS Advisors sold out of MacroGenics (MGNX) in Q2 2025, closing a stake of 48,646 shares — an estimated $61.8K sold.

ALPS Advisors first reported a position in MGNX in Q1 2015 and held it in 29 quarters. The position peaked at $2.12M in Q2 2021. 112 funds tracked by Wall St. Rank hold MGNX as of Q2 2025.

  • ALPS Advisors reported no remaining MacroGenics position as of Q2 2025 after selling out during the quarter.
  • ALPS Advisors sold 48,646 MacroGenics shares in Q2 2025, an estimated $61.8K.
  • ALPS Advisors first reported a position in MacroGenics in Q1 2015 and held it in 29 quarters.
  • ALPS Advisors's MacroGenics position peaked at $2.12M in Q2 2021.
  • 112 funds tracked by Wall St. Rank held MacroGenics as of Q2 2025.

Based on ALPS Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.